News & Presentations Filter by Category All 70 Company News 26 Media 17 Newsletter 7 Presentations & Webinars 21 Company News, All Michelle Long 2/1/24 Company News, All Michelle Long 2/1/24 Arovella completes key manufacturing step to progress ALA‐101 to clinic Read More Company News, All Michelle Long 20/11/23 Company News, All Michelle Long 20/11/23 Arovella receives R&D tax credit of $1.94m Read More Company News, All Michelle Long 10/11/23 Company News, All Michelle Long 10/11/23 AGM Chairman's Address and CEO & MD Presentation Read More Company News, All Michelle Long 12/10/23 Company News, All Michelle Long 12/10/23 Arovella licenses novel solid tumour targeting technology Read More Company News, All Michelle Long 11/7/23 Company News, All Michelle Long 11/7/23 Completion of oversubscribed Share Purchase Plan (SPP) Read More Company News, All Michelle Long 11/7/23 Company News, All Michelle Long 11/7/23 Arovella completes $4m placement & launches $1m SPP Read More Newer Posts
Company News, All Michelle Long 2/1/24 Company News, All Michelle Long 2/1/24 Arovella completes key manufacturing step to progress ALA‐101 to clinic Read More
Company News, All Michelle Long 20/11/23 Company News, All Michelle Long 20/11/23 Arovella receives R&D tax credit of $1.94m Read More
Company News, All Michelle Long 10/11/23 Company News, All Michelle Long 10/11/23 AGM Chairman's Address and CEO & MD Presentation Read More
Company News, All Michelle Long 12/10/23 Company News, All Michelle Long 12/10/23 Arovella licenses novel solid tumour targeting technology Read More
Company News, All Michelle Long 11/7/23 Company News, All Michelle Long 11/7/23 Completion of oversubscribed Share Purchase Plan (SPP) Read More
Company News, All Michelle Long 11/7/23 Company News, All Michelle Long 11/7/23 Arovella completes $4m placement & launches $1m SPP Read More
